Edition:
United States

Dr.Reddy's Laboratories Ltd (RDY.N)

RDY.N on New York Stock Exchange

37.89USD
12:17pm EDT
Change (% chg)

$-0.13 (-0.34%)
Prev Close
$38.02
Open
$37.99
Day's High
$38.28
Day's Low
$37.82
Volume
5,180
Avg. Vol
51,962
52-wk High
$42.78
52-wk Low
$28.49

About

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and... (more)

Overall

Beta: 0.40
Market Cap(Mil.): $6,026.99
Shares Outstanding(Mil.): 165.88
Dividend: 0.31
Yield (%): 0.86

Financials

  RDY.N Industry Sector
P/E (TTM): 34.56 29.30 32.55
EPS (TTM): 1.05 -- --
ROI: 8.09 14.23 13.82
ROE: 9.57 15.46 15.24

UPDATE 1-Indian drugmaker Dr. Reddy's Q3 profit surges on strong growth in emerging markets

Feb 1 Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 65.3 percent surge in quarterly profit on Friday, handily beating market expectations, helped by strong growth in emerging markets.

Feb 01 2019

Indian drugmaker Dr. Reddy's Q3 profit rises 65.3 pct, beats estimates

Feb 1 Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 65.3 percent surge in quarterly profit on Friday, driven by strong growth in emerging markets.

Feb 01 2019

Indivior plans cheaper opioid addiction drug if rivals launch copycats

Indivior Plc said on Tuesday it could launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, if rivals release generic versions of the drug.

Dec 18 2018

Earnings vs. Estimates